跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 昱閔
副教授
,
一般外科
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0003-0679-342X
電子郵件
yuminhuang
tmu.edu
tw
,
y.m.huang
yahoo.com
tw
h-index
430
引文
12
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2004
2025
每年研究成果
概覽
指紋
網路
專案
(1)
研究成果
(40)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Min Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Cancer
100%
Laparoscopic Surgery
95%
Cancer Surgery
82%
Rectum Cancer
72%
Minimally Invasive Surgery
68%
Neoplasm
61%
Rectum Tumor
60%
Systematic Review
60%
Meta-Analysis
60%
Maturity Onset Diabetes of the Young
58%
Colon Cancer
52%
Randomized Controlled Trial
52%
Surgery
41%
Disease
41%
Open Surgery
40%
Pancreatitis
40%
Hepatocellular Carcinoma
40%
Diabetes
38%
Body Mass Index
31%
Hernia
26%
Chemoradiation Therapy
25%
Cohort Analysis
24%
Patient with Type 2 Diabetes
24%
Surgical Anastomosis
23%
Da Vinci Surgical System
22%
Odds Ratio
22%
Postoperative Complication
22%
Gastric Bypass
21%
Gastric Bypass Surgery
21%
Operation Duration
20%
Meal
20%
Pseudoaneurysm
20%
Radiation Therapy
20%
Laparoscopic Sleeve Gastrectomy
20%
Cardiovascular Risk
20%
Antithrombotic
20%
Choledochal Cysts
20%
Intestine Perforation
20%
Hernioplasty
20%
Sleeve Gastrectomy
20%
Fatality
20%
Cigarette Smoking
20%
Cancer Survival
20%
Chyle
20%
Hematoma
20%
Obesity
20%
Breast Fibroadenoma
20%
Biopsy
20%
Small Intestine Obstruction
20%
Laparoscopic Cholecystectomy
20%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
42%
Liver Cell Carcinoma
40%
Histone Deacetylase
20%
Hydroxamic Acid
20%
Hematoma
20%
Colorectal Carcinoma
20%
Antifungal Agent
20%
Survivin
20%
Indocyanine Green
20%
Cardiovascular Risk
20%
Colorectal Cancer
20%
Anticoagulant Agent
20%
Remission
20%
Progression Free Survival
20%
Tubulin
20%
Ciclopirox
20%
Cardiovascular Disease
20%
Malignant Neoplasm
15%
Disease
15%
Overall Survival
15%
Ischemic Heart Disease
13%
Recurrent Disease
10%
Non Insulin Dependent Diabetes Mellitus
10%
Liver Disease
10%
Acute Abdomen
10%
Liver Cancer
10%
Cancer Staging
10%
Heat Shock Protein 90 Inhibitor
10%
Protein P53
8%
Tumor Growth
7%
DNA Binding Protein
5%
Anticoagulation Therapy
5%
Phase I Trials
5%
Prothrombin
5%
Observational Study
5%
Cytotoxicity
5%
Heat Shock Protein 90
5%
Survival Rate
5%
Ileus
5%
Drug Repositioning
5%
Thromboplastin
5%
Carcinogenesis
5%
Nonhistone Protein
5%
Visual Disorder
5%
Adverse Event
5%
Hepatitis B
5%
Solid Malignant Neoplasm
5%
Luminespib
5%
Warfarin
5%
Abdominal Pain
5%
